Vincent Richard G Insider Trades

Insider Trading History

Track insider trading activity for Vincent Richard G. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $517k 31,000 shares
Last Trade
Mar 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$234k 31,000 shares
$7.54
$16.69
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $33.4k 2,000 shares
Last Trade
Sep 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.1k 2,000 shares
$7.07
$16.69
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $7.48k 14,200 shares
Last Trade
Feb 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$130k 14,200 shares
$9.18
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $74.2k 140,922 shares
Last Trade
Jan 03, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$88k 8,868 shares
$9.92
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $147k 280,000 shares
Last Trade
Oct 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.55M 738,467 shares
$6.16
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Oct 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.55M 738,449 shares
$6.16
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $78.9k 149,790 shares
Last Trade
Jul 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$50.3k 7,069 shares
$7.11
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $82.6k 156,859 shares
Last Trade
Apr 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$171k 30,000 shares
$5.69
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $111k 210,000 shares
Last Trade
Feb 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.03M 210,000 shares
$19.20
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $66.8k 126,859 shares
Last Trade
Jan 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$90.3k 4,428 shares
$20.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $69.1k 131,287 shares
Last Trade
Jul 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$897k 43,125 shares
$20.80
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $46.4k 88,162 shares
Last Trade
Mar 24, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$73.5k 2,500 shares
$29.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $43.8k 83,162 shares
Last Trade
Jan 28, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$86k 2,500 shares
$34.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $42.5k 80,662 shares
Last Trade
Jan 27, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$167k 5,000 shares
$33.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $57.7k 109,579 shares
Last Trade
Jan 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.25M 109,579 shares
$38.80
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $37.2k 70,662 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.45M 29,867 shares
$48.60
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $147k 280,000 shares
Last Trade
Feb 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.5M 280,000 shares
$141.00
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $18.5k 35,120 shares
Last Trade
Mar 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.34M 35,120 shares
$66.60
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $18.5k 35,120 shares
Last Trade
Mar 17, 2020 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.34M 35,120 shares
$66.60
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Financial Officer
Holding Value $39.5k 75,000 shares
Last Trade
Sep 12, 2019 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.64M 75,000 shares
$115.20
$0.53

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up